No Data
No Data
Johnson & Johnson (JNJ.US) has completed the acquisition of V-Wave, which will generate $0.6 billion in research and development expenses in Q4.
Johnson & Johnson (JNJ.US) has completed the acquisition of the private medical devices company V-Wave Ltd. Around 0.6 billion US dollars of in-process research and development expenses (IPR&D) will be incurred in the fourth quarter of 2024.
J&J Closes V-Wave Deal, to Incur IPR&D Charge of $600M in Q4
Express News | Johnson & Johnson - J&J to Update Full-Year 2024 Financial Outlook on Oct 15, 2024
Johnson & Johnson Completes Acquisition Of V-Wave >JNJ
Express News | Johnson & Johnson Completes Acquisition of V-Wave
RBC Capital raised johnson & johnson's target price to $178.
RBC Capital: Raised johnson & johnson's target price from $175 to $178, maintaining an "outperform" rating.
loading...
loading...
JackChng : Wow. Next time I just follow your way
ひな☆彡 SOXL OP JackChng : Confirm with your strategy and enter. Use my entry as a reference.
CLL : Walk with these footsteps of yours
ひな☆彡 SOXL OP CLL : Sorry past few moves are garbage
CLL : No, bought a few and all of them are good.
View more comments...